Notice of Special Interest (NOSI): HEAL Initiative: Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose
Department of Health and Human Services ▸ National Institutes of Health ▸
Description
This grant opportunity invites research applications under the HEAL initiative to develop safe and effective medications for preventing or treating opioid and psychostimulant use disorders, with the aim of gaining FDA approval. Projects can include studies on new drugs, existing medications, biologics, and innovative drug delivery methods.
This Notice of Special Interest (NOSI) seeks research applications focusing on the scientific scope of the HEAL initiative to be submitted under PAR-22-200. The goal is to advance the development towards FDA approval of safe and effective medications to prevent or treat opioid and/or psychostimu…
Source
Grant ID
NOT-DA-23-010
Funding Source
Department of Health and Human Services ▸ National Institutes of Health ▸
Key Dates
Opportunity Released
September 28, 2022
Similar opportunities
- Notice of Special Interest (NOSI): HEAL Initiative: Grand Opportunity in Medications Development for Substance-Use Disorders
- Notice of Special Interest (NOSI): HEAL Initiative: Leveraging Inpatient Medical or Surgical Hospitalizations to Improve Outcomes for People Who Use Drugs
- Forecast for HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional
- Notice of Funding Opportunity for Translational Efforts in Drug Discovery for Non-Opioid Pain Treatments
- Notice of Special Interest (NOSI): HEAL Initiative: Development and Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech